reddit.com

Total Posts
52730
Total Predictions
12412
Success Rate
26.9%
Average Score
0.00

Posts

Reddit by _SG9 June 24, 2026

Specs were already net short the Nasdaq at a 1-year extreme before Tuesday's crash.

Found this digging around in the COT data. Going into Tuesday (KOSPI −9.99%, MU −13%, SK Hynix −12.5%) the big speculators were already net short Nasdaq futures at the 5th percentile of the past year. They'd been short for like two months while the index kept making highs. Funny part: …

Reddit by FrogletNuggie June 24, 2026

Wendys $WEN Halted

Reddit by Puzzleheaded-Test572 June 24, 2026

Shorting and scalping crude

Now that mr Trump has opened the strait of hormuz and weak iran has been castrated this Has been my favorite passtime. Easy $100 a day. This is not financial advice. Please gamble responsibly.

Reddit by PirateCorrect June 24, 2026

Holy smokes guys, we made them pause Wendy’s

It’s happening

Reddit by gypsy4343435 June 24, 2026

Wtf!!!

Reddit by M_digital June 24, 2026

Halted $WEN

Reddit by One-Dingo1220 June 24, 2026

CleanTech Vanadium ($CTV.V / $CTVFF): A Fluorspar Play Tied to AI Infrastructure?

I’ve been researching fluorspar recently and came across CleanTech Vanadium. The company is advancing fluorspar projects in the Illinois-Kentucky Fluorspar District (IKFD), historically the source of most U.S. fluorspar production. A few things that caught my attention: • Fluorspar is the primary commercial source of fluorine • Fluorine is required …

Reddit by NibletCarousel June 24, 2026

One feature I like to use

Slicer — the lazy man's execution on DRAMLook, sometimes you don't need a fancy VWAP curve. You just need your big order broken into smaller pieces so the market doesn't notice you. That's Slicer in one sentence. Frequency + slice size, moomoo handles the rest.DRAM is gonna get yanked around …

Reddit by MarketNewsFlow June 24, 2026

$ENTX - Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis (NASDAQ: ENTX)

***Seem Interesting -*** Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis (NASDAQ: ENTX). ***The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total …

Reddit by rndmxcsmmr June 24, 2026

Quad baconator loading